Skip to main content
DRIO
NASDAQ Industrial Applications And Services

DarioHealth Q2 2026: Cash Plunges to $6.6M, Losses Persist Despite Cost Cuts

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$7.66
Mkt Cap
$75.017M
52W Low
$5.845
52W High
$17.744
52W Position info
31% above low
Off High info
57% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

DRIO sits 31% above its 52-week low of $5.845.

Summary

DarioHealth's Q2 2026 10-Q shows cash collapsing to $6.6M from $21.8M, with $12.1M in operating cash burn. The July $23.5M offering bought time, but the underlying business is shrinking.


Key Events · Earnings and Guidance · DRIO

  • Cash Plummets to $6.6M

    Driven by $12.1M in operating cash burn, cash and equivalents fell from $21.8M at year-end 2025 to $6.6M at June 30, 2026.

  • Revenue Declines 11%

    Total revenue dropped to $10.8M in H1 2026 from $12.1M a year ago, as a 37% decline in services revenue to $5.4M was partially offset by consumer hardware growth.

  • Net Loss of $16.2M

    Despite aggressive cost cuts—R&D down 43%, SG&A down 11%—the company still lost $16.2M in H1 2026, though that marks an improvement from $22.2M last year.

  • July Offering Provided Lifeline

    A $23.5M registered direct offering closed July 23, 2026, at $6.80 per share, which management says funds operations for at least 12 months.


Analysis · DRIO · Industrial Applications And Services

A six-month cash collapse from $21.8 million to $6.6 million underscores the severity of DarioHealth's burn, with operating activities consuming $12.1 million. The net loss of $16.2 million, while narrower than last year, still dwarfs revenue of $10.8 million. Management points to the July $23.5 million offering as providing a 12-month runway, yet the balance sheet carries $31.1 million in long-term debt and only $55 million in equity. Aggressive cost-cutting is evident—R&D down 43%, sales and marketing down 11%—but revenue also contracted 11% year-over-year. This quarter reads as survival mode: the cash burn is real, and the recent capital raise is the only thing keeping the lights on.

At the time of this filing, DRIO was trading at $7.66 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $75M. The 52-week trading range was $5.84 to $17.74. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DRIO - Latest Insights

DRIO
Jul 22, 2026, 5:14 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $7.99
Real-time Price: $7.66 info
Change: -$0.330 (-4%) info
Market Cap: $75.017M info
DRIO
Jul 22, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $6.67
Real-time Price: $7.66 info
Change: +$0.990 (+15%) info
Market Cap: $75.017M info
DRIO
Jul 10, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.22
Real-time Price: $7.66 info
Change: +$0.440 (+6%) info
Market Cap: $75.017M info
DRIO
Jul 06, 2026, 7:30 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $7.16
Real-time Price: $7.66 info
Change: +$0.4992 (+7%) info
Market Cap: $75.017M info
DRIO
Jul 02, 2026, 7:30 AM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $6.60
Real-time Price: $7.66 info
Change: +$1.06 (+16%) info
Market Cap: $75.017M info